Article

Although there are many nonsurgical therapies available for the treatment of pain associated with osteoarthritis (OA), their long-term use and safety have not been systematically followed. Intra-articular hyaluronan therapy has been used in the treatment of symptoms associated with OA of the knee with a very favourable safety profile. Five intra-articular hyaluronan products are approved in the US. No systematic review of the safety and efficacy of their chronic use has been reported. Objective: To evaluate the literature on the efficacy and safety of repeat courses of hyaluronan therapy in patients with OA of the knee Data sources: MEDLINE, EMBASE, searched through October 2004. Study selection: Databases were searched using the terms hyaluronan, sodium hyaluronate, hyaluronic acid, hylan, hylan G-F 20, osteoarthritis, adverse events, repeat treatment, and multiple courses. Data synthesis: There are some data that support the benefit and safety of repeat treatment for all products. Data also indicate that one formulation of sodium hyaluronate (molecular weight [MW] 500-730 kDa) is well tolerated and as effective after multiple courses of treatment as it is after a single course. There is also clinical evidence that prolonged use of sodium hyaluronate (MW 500-730 kDa) may significantly decrease the rate of deterioration of joint structure. Localized severe acute inflammatory reactions reported with repeated treatment in some patients are not a class effect but may be linked to physicochemical characteristics of hylan-based treatment. Conclusions: Repeat courses of the hyaluronans are safe and effective in the treatment of pain associated with OA of the knee. (c) 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Langue : ANGLAIS

Tiré à part : OUI